Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION PLANS

v2.4.0.6
SHARE-BASED COMPENSATION PLANS
12 Months Ended
Dec. 31, 2012
Share-Based Compensation [Abstract]  
SHARE-BASED COMPENSATION PLANS
12. SHARE-BASED COMPENSATION PLANS
 
On June 1, 2011, our compensation committee approved the issuance of 660,000 shares of restricted stock, then valued at the closing price of our stock ($3.88), with no discount.  The majority of the shares (600,000) will vest on June 1, 2013.  The remaining shares have a three year vesting schedule as follows:  20,001 vested on June 1, 2012, 20,001 will vest on June 1, 2013 and 19,998 on June 1, 2014.  Vesting is contingent upon certain conditions, including continuous service of the individual recipients. The unvested shares are viewed as a series of individual awards and the related share-based compensation expense will be amortized into compensation expense on a straight-line basis as services are provided over the vesting period.
 
We recognized stock compensation expense of $1.2 million and $0.7 million for the twelve months ended December 31, 2012 and December 31, 2011, respectively. Share based compensation expense related to the amortization of the restricted stock issued is included in selling, general and administrative expense. At December 31, 2012 and 2011, we had deferred share-based compensation of $0.6 million and $1.8 million, respectively.
The following table summarizes our restricted stock activity relative to share-based compensation for 2012 and 2011:
 
   
2012
   
2011
 
   
 
 
Shares
   
Weighted
average
grant date
value (per
share)
   
 
 
 
Shares
   
Weighted
average
grant date
value (per
share)
 
Unvested at beginning of year
    660,000     $ 3.88       --     $ --  
                                 
Issued
    --       --       660,000       3.88  
Vested
    (20,001 )     3.88       --       --  
Forfeited
    --       --       --       --  
Unvested at end of year
    639,999       3.88       660,000       3.88  
 
In the second quarter of 2012 and 2011, we issued 6,000 shares of unrestricted stock in conjunction with director compensation, which was valued at $0.02 million in each year based on the closing price of our stock of $2.95 and $4.01, respectively, with no discount. Since the shares were fully vested at the date of grant, we recognized share-based compensation expense of $0.02 million in each year related to these grants.